-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OC-514 in Sarcopenia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.OC-514 in SarcopeniaDrug Details: OC-514 is under development for the treatment of sarcopenia, cancer cachexia, amyotrophic lateral...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OCE-205 in Hepatorenal Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.OCE-205 in Hepatorenal Syndrome Drug Details:OCE-205 is under development for the treatment of hepatorenal syndrome with...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OC-514 in Duchenne Muscular Dystrophy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.OC-514 in Duchenne Muscular DystrophyDrug Details: OC-514 is under development for the treatment of sarcopenia, cancer...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OC-001 in Merkel Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.OC-001 in Merkel Cell CarcinomaDrug Details:OC-001 is under development for the treatment of triple negative breast...
-
Product Insights
Dipka OC Project
The Dipka OC Project is a Coal mine in India. It is currently in operation. Dipka OC Project profile includes core details such as name, commodity, ore type, stage, type, owner and equity stakes, operator, size and location, as well as key operational data including production, capacity, strip ratio, start and end date, reserves and resources, grade. We also provide proprietary production forecasts, operating costs and counts of mobile equipment, plus selected key stakeholders and contact details. This is an...
-
Product Insights
Gevra OC Mine
The Gevra OC Mine is a Coal mine in India. It is currently in operation. Gevra OC Mine profile includes core details such as name, commodity, ore type, stage, type, owner and equity stakes, operator, size and location, as well as key operational data including production, capacity, strip ratio, start and end date, reserves and resources, grade. We also provide proprietary production forecasts, operating costs and counts of mobile equipment, plus selected key stakeholders and contact details. This is an...
-
Product Insights
Kusmunda OC Mine
The Kusmunda OC Mine is a Coal mine in India. It is currently in operation. Kusmunda OC Mine profile includes core details such as name, commodity, ore type, stage, type, owner and equity stakes, operator, size and location, as well as key operational data including production, capacity, strip ratio, start and end date, reserves and resources, grade. We also provide proprietary production forecasts, operating costs and counts of mobile equipment, plus selected key stakeholders and contact details. This is an...
-
Product Insights
Anaheim Ducks – OC Vibe Mixed-Use District – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Anaheim Ducks - OC Vibe Mixed-Use District - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Oregon Judicial Dept – OC Supreme Court Renovation – Oregon
Equip yourself with the essential tools needed to make informed and profitable decisions with our Oregon Judicial Dept - OC Supreme Court Renovation - Oregon report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Orange County Transportation/ Santa Ana EDD – OC Streetcar – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Orange County Transportation/ Santa Ana EDD - OC Streetcar - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
South Eastern Coalfields – Kusmunda OC Mine Infrastructure Expansion – Chhattisgarh
Equip yourself with the essential tools needed to make informed and profitable decisions with our South Eastern Coalfields - Kusmunda OC Mine Infrastructure Expansion - Chhattisgarh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Cystoid Macular Edema
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Cystoid Macular Edema Drug Details: Dexamethasone acetate (DexNP, OC-118, OCS-01) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Ocular Inflammation
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Ocular Inflammation Drug Details: Dexamethasone acetate (DexNP, OC-118, OCS-01) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Ocular Pain (Eye Pain)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Ocular Pain (Eye Pain) Drug Details: Dexamethasone acetate (DexNP, OC-118, OCS-01) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Acetate in Diabetic Macular Edema
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Acetate in Diabetic Macular Edema Drug Details: Dexamethasone acetate (DexNP, OC-118, OCS-01) is under...
-
Company Profile
![]()
OC Oerlikon Corporation AG – Company Profile
OC Oerlikon Corporation AG (Oerlikon) is a provider of advanced materials, surface solutions and materials processing. It develops production systems, components, and services for high-technology products, and provides turnkey solutions for the manufacturing of protective coatings for precision tools and components, and equipment for textile production and propulsion technology. Oerlikon serves customers in aerospace, automotive, general industries and tooling, energy, apparel and industrial textiles, and agriculture sectors in Europe, Asia-Pacific, North America and other regions. The company has sales, service...
Add to Basket -
Product Insights
New![]()
Net Present Value Model: BioNTech SE’s BNT-115
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. BioNTech SE's BNT-115 Drug Details: BNT-115 is under development for the treatment of ovarian cancer. The drug candidate is a liposomal formulated mRNA based...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KVA-12123 in Renal Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KVA-12123 in Renal Cell Carcinoma Drug Details: KVA-12123 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KVA-12123 in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KVA-12123 in Non-Small Cell Lung Cancer Drug Details: KVA-12123 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – KVA-12123 in Head And Neck Cancer Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. KVA-12123 in Head And Neck Cancer Squamous Cell Carcinoma Drug Details: KVA-12123 is under development...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.